The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data
Abstract
The current interest in undertaking cost‐effectiveness analyses alongside clinical trials has lead to the increasing availability of patient‐level data on both the costs and effectiveness of intervention. In a recent paper, we show how cost‐effectiveness analysis can be undertaken in a regression framework. In the current paper we develop a direct regression approach to cost‐effectiveness analysis by proposing the use of a system of seemingly unrelated regression equations to provide a more general method for prognostic factor adjustment with emphasis on sub‐group analysis. This more general method can be used in either an incremental cost‐effectiveness or an incremental net‐benefit approach, and does not require that the set of independent variables for costs and effectiveness be the same. Furthermore, the method can exhibit efficiency gains over unrelated ordinary least squares regression. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We will use a SURE model (seemingly unrelated regression equations) to allow for correlated residuals of the cost and effect equations while adjusting for potential confounders (eg, baseline differences in utility scores).110”
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Stein, L. I. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780170034003 · Cited by 1,902
The Importance of the Normality Assumption in Large Public Health Data Sets
Lumley, T., Diehr, P., Emerson, S., & Chen, L. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140546 · Cited by 1,803
Estimating log models: to transform or not to transform?
Manning, W. G., & Mullahy, J. (2001) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00086-8 · Cited by 1,790
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,621
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,103
Costs, effects and C/E‐ratios alongside a clinical trial
van Hout, B. A., Al, M., Gordon, G. S., & Rutten, F. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 963
How should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772
Multivariate Analysis: With Applications in Education and Psychology.
Duncan, G. T., & Timm, N. H. (1977) · Journal of the American Statistical Association · doi:10.2307/2286946 · Cited by 566
Hoch, J. S., Briggs, A. H., & Willan, A. R. (2002) · Health Economics · doi:10.1002/hec.678 · Cited by 535
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- Mullahy J, 1994, Valuing Health Care, 149
- 10.1002/hec.4730030505 · DOI
- Greene WH, 1993, Econometric Analysis, 486
Cited by
Sorted by citations
Manca, A., Hawkins, N., & Sculpher, M. J. (2005) · Health Economics · doi:10.1002/hec.944 · Cited by 1,024
Faria, R., Gomes, M., Epstein, D., & White, I. R. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0193-3 · Cited by 673
Early, Goal-Directed Therapy for Septic Shock — A Patient-Level Meta-Analysis
The PRISM Investigators (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701380 · Cited by 600
Rodgers, H., Bosomworth, H. J., Krebs, H. I., van Wijck, F., Howel, D., Wilson, N., Aird, L., Alvarado, N., Andole, S. N., Cohen, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31055-4 · Cited by 513
Riley, R. D., Abrams, K. R., Lambert, P. C., Sutton, A. J., & Thompson, J. R. (2006) · Statistics in Medicine · doi:10.1002/sim.2524 · Cited by 195
Nixon, R., Wonderling, D., & Grieve, R. (2010) · Health Economics · doi:10.1002/hec.1477 · Cited by 194
IMPROVE Trial Investigators (2017) · BMJ · doi:10.1136/bmj.j4859 · Cited by 163
Statistical Analysis of Cost‐effectiveness Data
Willan, A. R., & Briggs, A. H. (2006) · doi:10.1002/0470856289 · Cited by 155
Self-citationDeveloping Appropriate Methods for Cost-Effectiveness Analysis of Cluster Randomized Trials
Gomes, M., Ng, E. S. W., Grieve, R., Nixon, R. M., Carpenter, J. R., & Thompson, S. G. (2011) · Medical Decision Making · doi:10.1177/0272989x11418372 · Cited by 153
Hartman, E., Grieve, R., Ramsahai, R. R., & Sekhon, J. S. (2015) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12094 · Cited by 145
Handoll, H. H., Brealey, S., Rangan, A., Keding, A., Corbacho, B., Jefferson, L., Chuang, L., Goodchild, L. M., Hewitt, C. E., & Torgerson, D. J. (2015) · Health Technology Assessment · doi:10.3310/hta19240 · Cited by 152
Kleiboer, A., Smit, J., Bosmans, J., Ruwaard, J., Andersson, G., Topooco, N., Berger, T., Krieger, T., Botella, C., Baños, R., et al. (2016) · Trials · doi:10.1186/s13063-016-1511-1 · Cited by 133
Miyamoto, G. C., Franco, K. F. M., van Dongen, J. M., Franco, K. F. M., de Oliveira, N. T. B., Amaral, D. D. V., Branco, A. N. C., da Silva, M. L., van Tulder, M. W., & Cabral, C. M. N. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098825 · Cited by 139
Nixon, R. M., & Thompson, S. G. (2005) · Health Economics · doi:10.1002/hec.1008 · Cited by 128
van der Meij, E., Anema, J. R., Leclercq, W. K. G., Bongers, M. Y., Consten, E. C. J., Schraffordt Koops, S. E., van de Ven, P. M., Terwee, C. B., van Dongen, J. M., Schaafsma, F. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31113-9 · Cited by 114
Orgeta, V., Leung, P., Yates, L., Kang, S., Hoare, Z., Henderson, C., Whitaker, C. J., Burns, A. S., Knapp, M. R. J., Leroi, I., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19640 · Cited by 136
Clare, L., Kudlicka, A., Oyebode, J. R., Jones, R. W., Bayer, A., Leroi, I., Kopelman, M., James, I. A., Culverwell, A., Pool, J., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23100 · Cited by 123
An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis
Hunter, R. M., Baio, G., Butt, T., Stephen Morris, A., Round, J. A., & Freemantle, N. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0247-6 · Cited by 114
Manca, A., & Palmer, S. (2005) · Applied Health Economics and Health Policy · doi:10.2165/00148365-200504020-00001 · Cited by 114
A matching method for improving covariate balance in cost‐effectiveness analyses
Sekhon, J. S., & Grieve, R. (2011) · Health Economics · doi:10.1002/hec.1748 · Cited by 115
Griffin, S. C., Barber, J., Manca, A., Sculpher, M., Thompson, S. G., Buxton, M. J., & Hemingway, H. (2007) · BMJ · doi:10.1136/bmj.39129.442164.55 · Cited by 107
de Groof, E. J., Stevens, T. W., Eshuis, E. J., Gardenbroek, T. J., Bosmans, J. E., van Dongen, J. M., Mol, B., Buskens, C. J., Stokkers, P. C. F., Hart, A. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317539 · Cited by 106
McCarthy, I., O’Brien, M. F., Ames, C. P., Robinson, C., Errico, T. J., Polly, D. W., & Hostin, R. A. (2014) · Neurosurgical FOCUS · doi:10.3171/2014.3.focus1415 · Cited by 105
Moltó, A., Medina, C. L., den Bosch, F. E. V., Boonen, A. E. R. C. H., Webers, C., Dernis, E., van Gaalen, F. A., Soubrier, M., Claudepierre, P., Baillet, A. C., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219585 · Cited by 107
Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus
Reed, S., Anstrom, K. J., Bakhai, A., Briggs, A. H., Califf, R. M., Cohen, D. J., Drummond, M., Glick, H. A., Gnanasakthy, A., Hlatky, M. A., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.11.001 · Cited by 93
Self-citationRegression methods for cost-effectiveness analysis with censored data
Willan, A. R., Lin, D. Y., & Manca, A. (2004) · Statistics in Medicine · doi:10.1002/sim.1794 · Cited by 92
Self-citationLittlewood, E., Duarte, A., Hewitt, C. E., Knowles, S. E., Palmer, S., Walker, S., Andersen, P., Araya, R., Barkham, M., Bower, P., et al. (2015) · Health Technology Assessment · doi:10.3310/hta191010 · Cited by 92
Harvey, S. E., Parrott, F., Harrison, D. A., Sadique, Z., Grieve, R., Canter, R. R., McLennan, B. K., Tan, J. C., Bear, D. E., Segaran, E., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20280 · Cited by 94
Turner, D. A., Khioe, R. F. S., Shepstone, L., Lenaghan, E., Cooper, C. C., Gittoes, N. J. L., Harvey, N. C., Holland, R., Howe, A. C., McCloskey, E. V., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3381 · Cited by 88
Radford, K., Sutton, C., Sach, T., Holmes, J. A., Watkins, C. L., Forshaw, D., Jones, T. M., Hoffman, K., O’Connor, R. J., Tyerman, R., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22330 · Cited by 83
Williams, M. A., Williamson, E. M., Heine, P., Nichols, V. P., Glover, M. J., Dritsaki, M., Adams, J., Dosanjh, S., Underwood, M. R., Rahman, A., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19190 · Cited by 84
How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions?
Thompson, S., & Nixon, R. (2005) · Medical decision making · doi:10.1177/0272989x05276862 · Cited by 92
Brown, S. R., Tiernan, J. P., Biggs, K., Hind, D., Shephard, N., Bradburn, M. J., Wailoo, A., Alshreef, A., Swaby, L., Watson, A. J. M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20880 · Cited by 76
Cost-effectiveness of full endoscopic versus open discectomy for sciatica
Gadjradj, P. S., Broulíková, H. M., van Dongen, J. M., Rubinstein, S. M., Depauw, P. R. A. M., Vleggeert-Lankamp, C. L. A., Seiger, A., Peul, W. C., van Susante, J. L., van Tulder, M. W., et al. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-104808 · Cited by 73
A Pragmatic Multicentered Randomized Controlled Trial of Yoga for Chronic Low Back Pain
Chuang, L., Soares, M. O., Tilbrook, H. E., Cox, H., Hewitt, C. E., Aplin, J., Semlyen, A., Trewhela, A., Watt, I. S., & Torgerson, D. J. (2012) · Spine · doi:10.1097/brs.0b013e3182545937 · Cited by 72
The statistical approach in trial-based economic evaluations matters: get your statistics together!
Mutubuki, E. N., Alili, M. E., Bosmans, J. E., Oosterhuis, T., Snoek, F. J., Ostelo, R., van Tulder, M. W., & van Dongen, J. M. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06513-1 · Cited by 72
D’Amico, F., Rehill, A., Knapp, M. R. J., Aguirre, E., Donovan, H., Hoare, Z., Hoe, J., Russell, I. T., Spector, A. E., Streater, A., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.020 · Cited by 70
Acknowledging Patient Heterogeneity in Economic Evaluation
Grutters, J. P. C., Sculpher, M. J., Briggs, A. H., Severens, J. L., Candel, M. J. J. M., Stahl, J. E., Ruysscher, D. D., Boer, A., Ramaekers, B. L. T., & Joore, M. A. (2013) · PharmacoEconomics · doi:10.1007/s40273-012-0015-4 · Cited by 70
Self-citationBehavioural activation therapy for post-stroke depression: the BEADS feasibility RCT
Thomas, S., Drummond, A. E., Lincoln, N. B., Palmer, R., das Nair, R., Latimer, N. R., Hackney, G., Mandefield, L., Walters, S. J., Hatton, R. D., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23470 · Cited by 67
Jha, S., Walters, S. J., Bortolami, O., Dixon, S., & Alshreef, A. (2017) · Physiotherapy · doi:10.1016/j.physio.2017.06.003 · Cited by 64
Iliffe, S., Wilcock, J., Drennan, V. M., Goodman, C. M., Griffin, M., Knapp, M. R. J., Lowery, D., Manthorpe, J., Rait, G., & Warner, J. P. (2015) · Programme Grants for Applied Research · doi:10.3310/pgfar03030 · Cited by 66
GALA Collaborative Group, Gomes, M., Soares, M. O., Dumville, J. C., Lewis, S. C., Torgerson, D. J., Bodenham, A. R., Gough, M. J., & Warlow, C. P. (2010) · British journal of surgery · doi:10.1002/bjs.7110 · Cited by 62
Statistical Methods for Cost-Effectiveness Analyses That Use Data from Cluster Randomized Trials
Gomes, M., Grieve, R., Nixon, R. M., & Edmunds, W. J. (2011) · Medical Decision Making · doi:10.1177/0272989x11407341 · Cited by 64
Vu, T., Harris, A., Duncan, G., & Sussman, G. (2007) · Family Practice · doi:10.1093/fampra/cmm024 · Cited by 59
An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis
Franklin, M., Lomas, J., Walker, S., & Young, T. (2019) · PharmacoEconomics (Auckland) · doi:10.1007/s40273-019-00771-y · Cited by 48
Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy
van Waart, H., van Dongen, J. M., van Harten, W. H., Stuiver, M. M., Huijsmans, R., Hellendoorn-van Vreeswijk, J. A. J. H., Sonke, G. S., & Aaronson, N. K. (2018) · The European Journal of Health Economics · doi:10.1007/s10198-017-0936-0 · Cited by 56
Maguire, A., Clarkson, J. E., Douglas, G. V., Ryan, V., Homer, T., Marshman, Z., McColl, E., Wilson, N., Vale, L., Robertson, M., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24010 · Cited by 55
Thomas, K. S., Bradshaw, L. E., Sach, T., Batchelor, J., Lawton, S., Harrison, E., Haines, R., Ahmed, A. I., Williams, H. C., Dean, T., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002280 · Cited by 55
Palmer, R., Dimairo, M., Latimer, N., Cross, E., Brady, M., Enderby, P., Bowen, A., Julious, S., Harrison, M., Alshreef, A., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24190 · Cited by 53
Cost-effectiveness analysis for multinational clinical trials
Pinto, E. M., Willan, A. R., & OʼBrien, B. J. (2005) · Statistics in Medicine · doi:10.1002/sim.2078 · Cited by 53
Self-citationKreif, N., Grieve, R., & Sadique, Z. (2012) · Health Economics · doi:10.1002/hec.2806 · Cited by 54
Panel Data Methods and Applications to Health Economics
Jones, A. M. (2009) · Palgrave Macmillan UK eBooks · doi:10.1057/9780230244405_12 · Cited by 52
Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT
Coomarasamy, A., Harb, H. M., Devall, A., Cheed, V., Roberts, T. E., Goranitis, I., Ogwulu, C. B., Williams, H., Gallos, I. D., Eapen, A. K., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24330 · Cited by 51
Eriksson, J. K., Karlsson, J. A., Bratt, J., Petersson, I. F., van Vollenhoven, R., Ernestam, S., Geborek, P., & Neovius, M. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205060 · Cited by 50
METHODS FOR COVARIATE ADJUSTMENT IN COST‐EFFECTIVENESS ANALYSIS THAT USE CLUSTER RANDOMISED TRIALS
Gomes, M., Grieve, R., Nixon, R. M., Ng, E. S. W., Carpenter, J. R., & Thompson, S. G. (2012) · Health Economics · doi:10.1002/hec.2812 · Cited by 50
Conducting Trial-Based Economic Evaluations Using R: A Tutorial
Ben, Â. J., van Dongen, J. M., Alili, M. E., Eßer, J., Broulíková, H. M., & Bosmans, J. E. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01301-7 · Cited by 48
Kreif, N., Grieve, R., Radice, R., & Sekhon, J. S. (2013) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-013-0109-2 · Cited by 54
Ramaekers, B. L. T., Joore, M. A., & Grutters, J. P. C. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.013 · Cited by 47
Optimal treatment for obsessive compulsive disorder
Fineberg, N. A., Baldwin, D. S., Drummond, L. M., Wyatt, S., Hanson, J., Gopi, S., Kaur, S., Reid, J. E., Marwah, V., Sachdev, R. A., et al. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000237 · Cited by 49
Statistical analysis of cost–effectiveness data from randomized clinical trials
Willan, A. R. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.3.337 · Cited by 47
Self-citationManca, A., Lambert, P. C., Sculpher, M. J., & Rice, N. (2007) · Medical Decision Making · doi:10.1177/0272989x07302132 · Cited by 46
Harding, C., Chadwick, T. J., Homer, T. M., Lecouturier, J., Mossop, H., Carnell, S. C., King, W. J., Abouhajar, A., Vale, L. D., Watson, G. C., et al. (2022) · Health Technology Assessment · doi:10.3310/qoiz6538 · Cited by 46
van Dongen, J. M., Persoon, S., Jongeneel, G., Bosmans, J. E., Kersten, M. J., Brug, J., Nollet, F., Chinapaw, M. J. M., & Buffart, L. M. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00775-9 · Cited by 45
Towards Causal Benchmarking of Bias in Face Analysis Algorithms
Balakrishnan, G., Xiong, Y., Xia, W., & Perona, P. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-58523-5_32 · Cited by 48
Taylor, S. J., Carnes, D., Homer, K., Pincus, T., Kahan, B. C., Hounsome, N., Eldridge, S., Spencer, A., Diaz-Ordaz, K., Rahman, A., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04140 · Cited by 44
Eckermann, S. D., & Willan, A. R. (2011) · PharmacoEconomics · doi:10.2165/11587100-000000000-00000 · Cited by 44
Self-citationMethods for analyzing cost effectiveness data from cluster randomized trials
Bachmann, M. O., Fairall, L. R., Clark, A., & Mugford, M. (2007) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-5-12 · Cited by 44
Dakin, H., & Gray, A. M. (2017) · Statistics in Medicine · doi:10.1002/sim.7322 · Cited by 43
Fredborg, C., Odgaard, A., & Sørensen, J. R. (2020) · The Bone & Joint Journal · doi:10.1302/0301-620x.102b4.bjj-2018-1580.r3 · Cited by 43
Batchelor, J., Millington, A., Thomas, K. S., Akram, P., Azad, J., Bewley, A., Chalmers, J. R., Cheung, S. T., Duley, L., Eleftheriadou, V., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24640 · Cited by 44
Thomas, K. S., Bradshaw, L. E., Sach, T., Cowdell, F., Batchelor, J., Lawton, S., Harrison, E., Haines, R., Ahmed, A. I., Dean, T., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21160 · Cited by 43
Using propensity scores to estimate the cost–effectiveness of medical therapies
Indurkhya, A., Mitra, N., & Schrag, D. (2005) · Statistics in Medicine · doi:10.1002/sim.2267 · Cited by 42
Alili, M. E., van Dongen, J. M., Eßer, J., Heymans, M. W., van Tulder, M. W., & Bosmans, J. E. (2022) · Health Economics · doi:10.1002/hec.4603 · Cited by 41
Rosner, R., Sachser, C., Hornfeck, F., Kilian, R., Kindler, H., Muche, R., Müller, L. R. F., Thielemann, J., Waldmann, T., Ziegenhain, U., et al. (2020) · Trials · doi:10.1186/s13063-020-04922-x · Cited by 40
Patel, S., Ngunjiri, A. S. W., Hee, S. W., Yang, Y., Brown, S., Friede, T., Griffiths, F. E., Lord, J. L., Sandhu, H. K., Thistlethwaite, J. E., et al. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-282 · Cited by 40
Radford, K., Craven, K., McLellan, V., Sach, T., Brindle, R., Holloway, I., Hartley, S., Bowen, A., O’Connor, R. J., Stevens, J., et al. (2020) · Trials · doi:10.1186/s13063-020-04883-1 · Cited by 42
Knapp, M. R. J., Windmeijer, F., Brown, J., Kontodimas, S., Tzivelekis, S., Haro, J. M., Ratcliffe, M., Hong, J., & Novick, D. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826040-00006 · Cited by 37
Suman, A., Schaafsma, F. G., van Dongen, J. M., Elders, P. J. M., Buchbinder, R., van Tulder, M. W., & Anema, J. R. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030879 · Cited by 37
Alili, M. E., van Dongen, J. V., Goldfeld, K. S., Heymans, M., van Tulder, M. V., & Bosmans, J. (2020) · PharmacoEconomics (Auckland) · doi:10.1007/s40273-020-00946-y · Cited by 24
Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs
Hemming, C., Constable, L., Goulao, B., Kilonzo, M., Boyers, D., Elders, A., Cooper, K., Smith, A., Freeman, R., Breeman, S., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24130 · Cited by 35
Average Cost-Effectiveness Ratio with Censored Data
Bang, H., & Zhao, H. (2012) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2010.544437 · Cited by 35
Stratified Patient-Centered Care in Type 2 Diabetes
Slingerland, A. S., Herman, W. H., Redekop, K., Dijkstra, R. F., Jukema, J. W., & Niessen, L. W. (2013) · Diabetes Care · doi:10.2337/dc12-1865 · Cited by 34
Dixon, S., Hill, H. R., Flight, L., Khetrapal, P., Ambler, G., Williams, N. R., Brew‐Graves, C., Kelly, J. D., Catto, J. W. F., iROC Study Team, et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17255 · Cited by 33
Ulug, P., Hinchliffe, R. J., Sweeting, M. J., Gomes, M., Thompson, M. T., Thompson, S. G., Grieve, R., Ashleigh, R., Greenhalgh, R. M., & Powell, J. T. (2018) · Health Technology Assessment · doi:10.3310/hta22310 · Cited by 33
van de Graaf, V. A., van Dongen, J. M., Willigenburg, N. W., Noorduyn, J. C. A., Butter, I. K., de Gast, A., Saris, D. B. F., van Tulder, M. W., & Poolman, R. W. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-100065 · Cited by 33
Leurent, B., Gomes, M., Cro, S., Wiles, N., & Carpenter, J. R. (2019) · Health Economics · doi:10.1002/hec.3963 · Cited by 33
Hoch, J. S. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.04.010 · Cited by 33
Self-citationWilliams, A. J., van Dongen, J. M., Kamper, S. J., O’Brien, K. M., Wolfenden, L., Yoong, S. L., Hodder, R. K., Lee, H., Robson, E. K., Haskins, R., et al. (2018) · European Journal of Pain · doi:10.1002/ejp.1334 · Cited by 32
Multilevel models for estimating incremental net benefits in multinational studies
Grieve, R., Nixon, R. M., Thompson, S. G., & Cairns, J. (2006) · Health Economics · doi:10.1002/hec.1198 · Cited by 32
Ng, E. S. W., Diaz‐Ordaz, K., Grieve, R., Nixon, R. M., Thompson, S. G., & Carpenter, J. R. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280213511719 · Cited by 30
The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions
Manca, A., Sculpher, M. J., & Goeree, R. A. (2010) · PharmacoEconomics · doi:10.2165/11537760-000000000-00000 · Cited by 30
Methods for Estimating Subgroup Effects in Cost-Effectiveness Analyses That Use Observational Data
Kreif, N., Grieve, R., Radice, R., Sadique, Z., Ramsahai, R. R., & Sekhon, J. S. (2012) · Medical Decision Making · doi:10.1177/0272989x12448929 · Cited by 30
Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions
Hoch, J. S., & Dewa, C. S. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725100-00001 · Cited by 30
Self-citationKolovos, S., Kenter, R. M. F., Bosmans, J. E., Beekman, A. T. F., Cuijpers, P. J., Kok, R. N., & van Straten, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.025 · Cited by 29
Karapinar‐Çarkit, F., van der Knaap, R., Bouhannouch, F., Borgsteede, S. D., Janssen, M. J. A., Siegert, C. E. H., Egberts, T. C. G., van den Bemt, P. M. L. A., van Wier, M. F., & Bosmans, J. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174513 · Cited by 29
Assessing the Impact of EQ-5D Country-specific Value Sets on Cost-utility Outcomes
van Dongen, J. M., Ben, Â. J., Finch, A. P., Rossenaar, M. M. M., Biesheuvel-Leliefeld, K. E. M., Apeldoorn, A. T., Ostelo, R., van Tulder, M. W., van Marwijk, H., & Bosmans, J. E. (2020) · Medical Care · doi:10.1097/mlr.0000000000001417 · Cited by 29
Winkler, P., Koeser, L., Kondrátová, L., Broulíková, H. M., Páv, M., Kališová, L., Barrett, B., & McCrone, P. (2018) · Lancet psychiatry · doi:10.1016/s2215-0366(18)30388-2 · Cited by 25
Value of Information and Pricing New Healthcare Interventions
Willan, A. R., & Eckermann, S. D. (2012) · PharmacoEconomics · doi:10.2165/11592250-000000000-00000 · Cited by 28
Self-citationStracke, M., Gilbert, K., Kieser, M., Klose, C., Krisam, J., Ebert, D. D., Buntrock, C., & Christiansen, H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00054 · Cited by 30
Baka, A., van der Zweerde, T., Lancee, J., Bosmans, J. E., & van Straten, A. (2021) · Behavioral Sleep Medicine · doi:10.1080/15402002.2021.1901708 · Cited by 29
Metadata
- Authors
- Willan, A. R., Briggs, A. H., & Hoch, J. S.
- Affiliations
- University of Toronto (CA)
- University of Oxford (GB)
- Western University (CA)
- Corresponding author
- Willan, Andrew R.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2003-12-15
- Volume
- 13
- Issue
- 5
- Pages
- 461-475
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2069086045
- Cited by
- 364
- References
- 33
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 28 · 2023: 20 · 2022: 25 · 2021: 33 · 2020: 44 · 2019: 18 · 2018: 26 · 2017: 24 · 2016: 13 · 2015: 14 · 2014: 14 · 2013: 11 · 2012: 10
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Health Economics (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- cost-effectiveness analysis, covariate adjustment, subgroup analysis, seemingly unrelated regression, individual patient data, incremental cost-effectiveness, incremental net benefit, prognostic factors
- MeSH terms
- Adult, Canada, Cost-Benefit Analysis, Humans, Middle Aged, Regression Analysis, Models, Statistical, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review